ShareHope Medicine Co Ltd (8403) - Total Assets
Based on the latest financial reports, ShareHope Medicine Co Ltd (8403) holds total assets worth NT$6.76 Billion TWD (≈ $213.01 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of ShareHope Medicine Co Ltd for net asset value and shareholders' equity analysis.
ShareHope Medicine Co Ltd - Total Assets Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's total assets have evolved over time, based on quarterly financial data.
ShareHope Medicine Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
ShareHope Medicine Co Ltd's total assets of NT$6.76 Billion consist of 47.8% current assets and 52.2% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 20.6% |
| Accounts Receivable | NT$1.23 Billion | 17.3% |
| Inventory | NT$292.26 Million | 4.1% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how ShareHope Medicine Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 8403 market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: ShareHope Medicine Co Ltd's current assets represent 47.8% of total assets in 2024, an increase from 47.5% in 2017.
- Cash Position: Cash and equivalents constituted 20.6% of total assets in 2024, up from 15.3% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 17.3% of total assets.
ShareHope Medicine Co Ltd Competitors by Total Assets
Key competitors of ShareHope Medicine Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
ShareHope Medicine Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.02 | 1.78 | 1.93 |
| Quick Ratio | 1.82 | 1.61 | 1.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.60 Billion | NT$1.39 Billion | NT$1.54 Billion |
ShareHope Medicine Co Ltd - Advanced Valuation Insights
This section examines the relationship between ShareHope Medicine Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -4.6% |
| Total Assets | NT$7.10 Billion |
| Market Capitalization | $93.23 Million USD |
Valuation Analysis
Below Book Valuation: The market values ShareHope Medicine Co Ltd's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: ShareHope Medicine Co Ltd's assets decreased by 4.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for ShareHope Medicine Co Ltd (2017–2024)
The table below shows the annual total assets of ShareHope Medicine Co Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$7.10 Billion ≈ $223.74 Million |
-4.62% |
| 2023-12-31 | NT$7.45 Billion ≈ $234.58 Million |
+0.92% |
| 2022-12-31 | NT$7.38 Billion ≈ $232.44 Million |
+20.69% |
| 2021-12-31 | NT$6.11 Billion ≈ $192.59 Million |
+7.51% |
| 2020-12-31 | NT$5.69 Billion ≈ $179.13 Million |
+34.91% |
| 2019-12-31 | NT$4.21 Billion ≈ $132.77 Million |
+9.48% |
| 2018-12-31 | NT$3.85 Billion ≈ $121.27 Million |
+14.52% |
| 2017-12-31 | NT$3.36 Billion ≈ $105.90 Million |
-- |
About ShareHope Medicine Co Ltd
ShareHope Medicine Co., Ltd. provides integrated medical services in Taiwan. It is involved in the health management and operation activities; human resource dispatch of professional medical staff; provision of medical, pharmaceutical, and health devices, as well as long-distance health care services; and rental of medical devices. ShareHope Medicine Co., Ltd. was founded in 2003 and is based in … Read more